Short-term testosterone use among transmasculine and gender diverse (TMGD) individuals is not associated with an increased risk for gynecological cancers.

AstraZeneca’s record seventh year of plenary data at ASCO furthers ambition to redefine breast cancer care and transform outcomes in gastric cancer: Cambridge, UK Thursday, May ...

Burgess said the disease is relatively common. “We know that in the United States, one in eight men are diagnosed with ...

Doctors not involved in Biden's care said his diagnoses shows the challenges of screening for prostate cancer.

Joe Biden's prostate cancer, marked by a high Gleason score and bone metastasis, is likely to be hormone-sensitive. Experts ...

Former U.S. President Joe Biden's office announced that he has been diagnosed with "aggressive" prostate cancer, which has ...

Obama was just the latest of several political figures to send the former president their well wishes, including former Vice ...

Former President Joe Biden has been diagnosed with an aggressive form of prostate cancer that has spread to his bones, ...

Discover common daily habits that may be increasing your cancer risk, from processed meats to sleep deprivation, and learn ...

Wander says this underscores the importance of using next-generation sequencing after a patient’s cancer progresses on anti-estrogen therapy, since ESR1 mutations may be missed if oncologists are ...

Progesterone receptor (PR) is a key player in the pathophysiology of ER+/PR+ breast cancer. PR is an estrogen receptor dependent gene product meaning estrogen signaling regulates PR expression.